About: Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$0.35 (+1.47%)
COVASXCleo Diagnostics Ltd
Cleo Diagnostics Ltd share price
COV price activity
Último preço
$ 0,350
Variação (24h)
0,01 AUD (1,47%)
Volume
115.38K
Volume (média 4 sem.)
-
Abertura
$ 0,33
Variação do dia
$ 0,33 - $ 0,36
Fechamento anterior
$ 0,34
Último negócio
10 Sep, 2:09 am GMT+0
Atrasado
10 Sep, 2:09 am GMT+0
COV price performance
Atrasado
10 Sep, 2:09 am GMT+0
quote.marketSignals